SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Progen Industries Ltd (PGLAF)
An SI Board Since March 1999
Posts SubjectMarks Bans Symbol
349 4 0 PGLA
Emcee:  Jorgen Jensen Type:  Unmoderated
Introduction Market Data Compact
This is a forum to discuss Progen Industries, a small biotech
company located in Brisbane, Australia.
Its main research is focused on the investigation of sugar
based molecules for use as potential anti-cancer (PI-88),
anti-coagulant (PI-99), and anti-inflammatory therapeutics.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
349Progen’s PI-88 Phase3 now recruiting patients clinicaltrials.gov Stock code: PGHenrik-12/20/2007
348Thursday, 1 November 2007 - PGL.AX closed up 10% @ A$2.86 (US$2.67) Headline fHenrik-11/1/2007
347For access to Progen’s Open Briefing® - CEO on PI-88 Fast Track, please cliHenrik-9/28/2007
346<b>FDA Fast Tracks PI-88 for the Treatment of Post Resection iver Cancer&lHenrik-9/24/2007
345Orphan Drug Designation for PI-88 granted in the EU Brisbane, Australia. 20 SeHenrik-9/20/2007
344Progen Pharmaceuticals to Present at Thomas Weisel Partners Healthcare ConferencHenrik-9/6/2007
343I am puzzled by the trading. Down about 3% at your place, and then opened here wJorgen Jensen-4/16/2007
342PGLA - Phase 3 Patient Enrolment Planned for Second Half of 2007 15 April 2007.Henrik-4/15/2007
341PI-88 Data to be Presented at Key International Conferences Brisbane, AustraliHenrik-3/12/2007
340PR from Progen .................................................. Liver Cancer;Henrik-1/26/2007
339PI-88 now has licensing appeal Kayt Davies Thursday, 18 January 2007 INTERSUIHenrik-1/19/2007
338 13 December 2006 Progen Reports Positive Results for Phase 2 Liver Cancer TrialJorgen Jensen-12/12/2006
337FDA Provides Manufacturing Clearance for Phase III Trial of Anti-Cancer Drug WedJorgen Jensen-11/29/2006
336US hedge fund nibbles at Progen - PGLA:NASDAQ One of the world's biggest heHenrik-11/15/2006
335Annual report available at www.progen.com.au In The News... 30 October 2006 AGHenrik-10/29/2006
334Progen changes its NASDAQ ticker symbol to PGLA Brisbane, Australia. 4 October Henrik-10/4/2006
333Progen research report intersuisse.com.auHenrik-7/27/2006
332Corporate Presentation May-June 2006 * Who and what we are * Where we are * WheHenrik-5/30/2006
331Webcast: Progens teleconference on announcement made 16 May regarding plans for Henrik-5/17/2006
330The hard sell of PI-88 Liam Walsh May 17, 2006 JUSTUS Homburg is one of a neHenrik-5/16/2006
329Traders corner Kevin Andrusiak May 17, 2006 LIVER cancer is not the nicest of Henrik-5/16/2006
328PROGEN PREPARES FOR ACCELERATED CLINICAL DEVELOPMENT OF PI-88 FOLLOWING FDA MEETHenrik-5/16/2006
327Very interesting, and the new CEO was announced on 2-19! Have you ordered your Jorgen Jensen-2/23/2006
326Snippets from another board incl. a rumoured takeover bid in the making. PostedHenrik-2/23/2006
325Brisbane, Australia 20 February 2006. Progen Industries (ASX: PGL) today announcJorgen Jensen-2/22/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News